Diversified Healthcare Trust vs Equity LifeStyle Properties
DHC and ELS side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DHC and ELS compare
Equity LifeStyle Properties is the larger company, worth 6.7 times as much as Diversified Healthcare Trust ($12.0B against $1.8B).
Equity LifeStyle Properties grew revenue faster over the last twelve months (3.2% versus −3.8% for Diversified Healthcare Trust).
Equity LifeStyle Properties keeps more of each dollar of sales as profit, with a net margin of 25.6% compared with −10.3% at Diversified Healthcare Trust.
Both pay dividends: Diversified Healthcare Trust yields 0.54% and Equity LifeStyle Properties 3.5%.
Equity LifeStyle Properties scores higher on the StockData Score (9 against 3 for Diversified Healthcare Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DHC | ELS |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $12.0B |
| Share price | $7.35 | $61.53 |
| Change, 1 year | 63.3% | −2.4% |
| Change, 5 years | 131% | −27.4% |
| Beta (5Y) | 1.11 | 0.40 |
| Employees | 600 | 3,200 |
| StockData Score | ||
| Total score | 3 | 9 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 | 6 (better) |
| Health score | 0 | 0 |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/E | – | 30.6× |
| P/S | 1.2× (better) | 7.6× |
| P/B | 1.2× (better) | 6.9× |
| EV/EBITDA | 7.3× (better) | 19.1× |
| PEG | – | 3.21 |
| Fair value | $6.46 | $53.10 |
| Margin of safety | −13.8% (better) | −15.9% |
| Growth | ||
| Revenue growth (TTM) | −3.8% | 3.2% (better) |
| Revenue growth, 5Y average | −1.2% | 6.5% (better) |
| Net income growth (TTM) | – | 1.3% |
| EPS growth (TTM) | – | 2.0% |
| EPS growth, 5Y average | – | 10.0% |
| Profitability | ||
| Operating margin | – | 26.1% |
| Net margin | −10.3% | 25.6% (better) |
| Return on equity | −9.5% | 23.1% (better) |
| Return on invested capital | – | 19.0% |
| Financial health | ||
| Interest coverage | – | 3.0× |
| Altman Z-score | 1.09 | 2.33 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.54% | 3.5% (better) |
| Payout ratio | – | 102% |
| Years of dividend growth | 0 | 1 (better) |
| Dividend growth, 5Y average | −26.0% | – |
| Buyback yield | 0.16% | – |
| Shareholder yield | 0.70% | 3.5% (better) |
| Ownership | ||
| Held by institutions | 84.9% | 108% |
| Held by insiders | 15.2% | 0.71% |
| Insider net buying, 12 months | $97.8K (better) | −$202K |
| Short interest, % of float | – | 5.5% |
Go deeper
- DHC stock overview
- DHC income statement
- DHC valuation and score
- ELS stock overview
- ELS income statement
- ELS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.